Genotech Corporation (XKON:066830)
South Korea · Delayed Price · Currency is KRW 1,097.00
+23.00 (2.14%)
At close: Feb 13, 2026
Genotech Revenue
In the year 2015, Genotech had annual revenue of 7.28B KRW with 12.91% growth.
Revenue
7.28B
Revenue Growth
+12.91%
P/S Ratio
0.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2015 | 7.28B | 832.48M | 12.91% |
| Dec 31, 2014 | 6.45B | 162.78M | 2.59% |
| Dec 31, 2013 | 6.29B | -648.95M | -9.36% |
| Dec 31, 2012 | 6.94B | 395.87M | 6.05% |
| Dec 31, 2011 | 6.54B | -381.58M | -5.51% |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADBiotech | 14.57B |
| Eutilex.Co.,Ltd | 10.54B |
| The Technology | 8.75B |
| OLIPASS | 5.25B |
| Kainos Medicine | 938.87M |
| Angiolab | 702.62M |
| Apures | 517.33M |
| Epibiotech | 449.62M |